Drawing for PLEOTREATMENT

USPTO serial 79142345

PLEOTREATMENT

Reviewed by CopyMark Law Group

Reg. 4661507Status 404
Filing date
Status date
Registration date
Dec 30, 2014
Examiner
VAGHANI, MAYUR C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PLEOTREATMENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey A. Smith

Jeffrey A. Smith Millen White Zelano and Branigan, PC2200 Clarendon Blvd Suite 1400Arlington, VA 22201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Creation, compilation, management of databases and central data files in the field of medicine and clinical trials Database management, collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics; compilation and systematization of data into a central file; public relations; business information, namely, provision of commercial information in the fields of pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trialsSECTION 71 - CANCELLED—
041Training services in the field of medicine and clinical trials; publishing writing and publication of books and texts other than advertising texts; non-downloadable electronic publication of texts in the nature of articles, magazines, brochures in the field of online medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions, seminars in the field of medicine; teaching in the field of medicine and clinical trialsSECTION 71 - CANCELLED—
042Pharmaceutical research and development; scientific research for medical purposes in the field of medicine and clinical trials; Scientific and clinical research studies in the fields of medicine, the prevention, treatment and management of illness, health care delivery; chemical and biological analysis, research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research for the diagnosis, prevention and treatment of diabetes and obesity and any other illness; biological research services in the field of chemical, biological and pharmaceutical products; software design and development; scientific laboratory services; research on chemical reagents for medical use, namely, biomarkersSECTION 71 - CANCELLED—
044Medical services; pharmacy advice; Providing information about the diagnosis and treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, and awareness and information regarding the treatment regarding the aforementioned diseases and illnessesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 31, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 31, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 31, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 8, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 7, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 7, 2022INPCINVALIDATION PROCESSED—
Mar 16, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 16, 2021C71TCANCELLED SECTION 71—
Dec 30, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 7, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 8, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 26, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 8, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 1, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 1, 2015FIMPFINAL DISPOSITION PROCESSED—
Mar 30, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 30, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 24, 2014GPNXNOTIFICATION PROCESSED BY IB—
Oct 14, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 14, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 8, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 8, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 24, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 10, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 10, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 10, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Sep 10, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 10, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 10, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 3, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 27, 2014ALIEASSIGNED TO LIE—
Aug 25, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 14, 2014RFNTREFUSAL PROCESSED BY IB—
Feb 25, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 25, 2014RFRRREFUSAL PROCESSED BY MPU—
Feb 25, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 25, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2014DOCKASSIGNED TO EXAMINER—
Feb 21, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 19, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 17, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance